July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Progression to late AMD: Role of SDOCT-biomarkers in patients with drusenoid PED
Author Affiliations & Notes
  • Julia Lemke
    Department of Ophthalmology, University Hospital Cologne, Cologne, Germany
  • Vasilena Sitnilska
    Department of Ophthalmology, University Hospital Cologne, Cologne, Germany
  • Eveline Kersten
    Department of Ophthalmology, Radboud university medical center, Nijmegen, Netherlands
  • Tina Schick
    Department of Ophthalmology, University Hospital Cologne, Cologne, Germany
  • Philip Enders
    Department of Ophthalmology, University Hospital Cologne, Cologne, Germany
  • Carel C B Hoyng
    Department of Ophthalmology, Radboud university medical center, Nijmegen, Netherlands
  • Anneke I Den Hollander
    Department of Ophthalmology, Radboud university medical center, Nijmegen, Netherlands
  • Sascha Fauser
    F. Hoffmann-La Roche AG, Basel, Switzerland
  • Lebriz Altay
    Department of Ophthalmology, University Hospital Cologne, Cologne, Germany
  • Footnotes
    Commercial Relationships   Julia Lemke, None; Vasilena Sitnilska, None; Eveline Kersten, None; Tina Schick, None; Philip Enders, None; Carel Hoyng, None; Anneke Den Hollander, None; Sascha Fauser, F. Hoffmann- La Roche AG (E); Lebriz Altay, None
  • Footnotes
    Support  FOR2240
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 2377. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Julia Lemke, Vasilena Sitnilska, Eveline Kersten, Tina Schick, Philip Enders, Carel C B Hoyng, Anneke I Den Hollander, Sascha Fauser, Lebriz Altay; Progression to late AMD: Role of SDOCT-biomarkers in patients with drusenoid PED. Invest. Ophthalmol. Vis. Sci. 2018;59(9):2377.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To evaluate the role of hyperreflective foci (HF) and reticular drusen (RD) for progression to late age-related macular degeneration (AMD) in high-risk patients with drusenoid PED (dPED).

Methods : This case-control study included 73 patients with dPED due to AMD, without any signs of choroidal neovascularization (CNV) or central geographic atrophy (GA), from European genetic database with follow-up of at least 5 years. DPED was defined as a well-defined large druse ≥360µm detected on color fundus photographs (FP) and spectral-domain optical coherence tomography (SDOCT). Grading was performed for AMD, for presence of HF (≥10 lesions with reflectivity equal/higher than the retinal pigment epithelium) and for RD. Logistic regression analysis for development of late AMD included age, gender, smoking, HF and RD.

Results : During a mean follow-up time of 6.13±1.12 years (range 4.5-10.4 years), 40 of 73 patients (54.8%) developed late AMD (CNV n=12, GA n=20, mixed type n=8). DPED patients with either RD (Odds ratio (OR)=6.79, 95% Confidence interval (CI): 0.79-58.33, p=0.081) or HF (OR=4.60, 95% CI:1.40-15.12, p=0.012) showed increased likelihood of developing late AMD after 5 years in comparison to dPED patients without these features. The association of presence of HF in dPED patients and the development of late AMD was still significant after adjusting for age, gender and smoking (OR=4.71, 95% CI:1.09-20.30, p=0.038), whereas RD were not predictive (p=0.81).

Conclusions : Patients with simultaneous occurrence of dPED and ≥10 HF in SDOCT have an increased likelihood of progression to late AMD during 5 years. In those cases intensified monitoring seems advisable to detect conversion and treat as early as possible.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×